FMP
NASDAQ
229.72 USD
-13.55 (-5.9%)
Dr. Martine A. Rothblatt J.D., M.B.A., Ph.D.
Healthcare
Biotechnology
https://www.unither.com
NASDAQ
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertension (PAH) to diminish symptoms associated with exercise; Tyvaso, an inhaled formulation of prostacyclin analogue treprostinil to enhance the exercise ability in PAH patients and pulmonary hypertension associated with interstitial lung disease (PH-ILD); Orenitram, a tablet dosage form of treprostinil to enhance the exercise capacity in PAH patients; Unit...
0001082554
US91307C1027
91307C102
1040 Spring Street
301 608 9292
US
1,168
Jun 17, 1999
0001082554
NASDAQ
Biotechnology
Healthcare
91307C102
US91307C1027
US
229.72
0.52
406.55k
10.81B
-
204.44-261.54
410.3
-
-
-
-
11.6
-
https://www.unither.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.